1. Probing the Anticancer Action of Oridonin with Fluorescent Analogues: Visualizing Subcellular Localization to Mitochondria
    Shengtao Xu et al, 2016, J. Med. Chem. CrossRef
  2. Oridonin upregulates PTEN through activating p38 MAPK and inhibits proliferation in human colon cancer cells
    QIU-XIANG WU et al, 2016 CrossRef
  3. Oridonin inhibits the proliferation of human colon cancer cells by upregulating BMP7 to activate p38 MAPK
    CHUN-MEI REN et al, 2016 CrossRef
  4. Oridonin induces apoptosis in human oral cancer cells via phosphorylation of histone H2AX
    In-Hyoung Yang et al, 2017, Eur J Oral Sci CrossRef
  5. Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer’s disease
    Ean-Jeong Seo et al, 2017, Pharmacological Research CrossRef
  6. Phytotherapeutics oridonin and ponicidin show additive effects combined with irradiation in pancreatic cancer in vitro
    Jakob Liermann et al, 2017 CrossRef
  7. Enhancement of the effects of gemcitabine against pancreatic cancer by oridonin via the mitochondrial caspase-dependent signaling pathway
    DIAN-LEI LIU et al, 2014 CrossRef
  8. Oridonin promotes G2/M arrest in A549 cells by facilitating ATM activation
    Mingxing Zheng et al, 2017 CrossRef
  9. A novel combination of oridonin and valproic acid in enhancement of apoptosis induction of HL-60 leukemia cells
    MEIYAN SHI et al, 2016 CrossRef
  10. Oridonin induces apoptosis through the mitochondrial pathway in human gastric cancer SGC-7901 cells
    SHIYONG GAO et al, 2016 CrossRef
  11. 13-Acetoxysarcocrassolide Induces Apoptosis on Human Gastric Carcinoma Cells Through Mitochondria-Related Apoptotic Pathways: p38/JNK Activation and PI3K/AKT Suppression
    Ching-Chyuan Su et al, 2014, Marine Drugs CrossRef
  12. Neurogenic Traditional Chinese Medicine as a Promising Strategy for the Treatment of Alzheimer’s Disease
    Sravan Sreenivasmurthy et al, 2017, IJMS CrossRef
  13. Inhibition of the JNK/MAPK signaling pathway by myogenesis-associated miRNAs is required for skeletal muscle development
    Shu-Juan Xie et al, 2018, Cell Death Differ CrossRef
  14. Potential mechanisms of action of dietary phytochemicals for cancer prevention by targeting cellular signaling transduction pathways
    HONGYU CHEN et al, 2018, J. Agric. Food Chem. CrossRef
  15. The Antipancreatic Cancer Activity of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2
    Bo Chen et al, 2015, DNA and Cell Biology CrossRef
  16. Apoptosis and autophagy induced by DVDMs-PDT on human esophageal cancer Eca-109 cells
    Yin Shi et al, 2018, Photodiagnosis and Photodynamic Therapy CrossRef
  17. Oridonin induces growth inhibition and apoptosis in human gastric carcinoma cells by enhancement of p53 expression and function
    Enxu Bi et al, 2018, Braz J Med Biol Res CrossRef
  18. ROS/JNK/c-Jun axis is involved in oridonin-induced caspase-dependent apoptosis in human colorectal cancer cells
    Di Zhang et al, 2019, Biochemical and Biophysical Research Communications CrossRef
  19. Silibinin inhibited autophagy and mitochondrial apoptosis in pancreatic carcinoma by activating JNK/SAPK signaling
    Xiaokai Zhang et al, 2019, Pathology - Research and Practice CrossRef
  20. Use of herbal medicines and natural products: An alternative approach to overcoming the apoptotic resistance of pancreatic cancer
    Lin Li et al, 2014, The International Journal of Biochemistry & Cell Biology CrossRef
  21. Oridonin Attenuates Aβ1–42-Induced Neuroinflammation and Inhibits NF-κB Pathway
    Sulei Wang et al, 2014, PLoS ONE CrossRef
  22. Nobiletin suppresses the proliferation and induces apoptosis involving MAPKs and caspase-8/-9/-3 signals in human acute myeloid leukemia cells.
    Pei-Ching Hsiao et al, 0 CrossRef
  23. Oridonin alters the expression profiles of MicroRNAs in BxPC-3 human pancreatic cancer cells
    Zhifang Gui et al, 2015, BMC Complement Altern Med CrossRef
  24. Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects
    Jie Yang et al, 2015, Biomedicine & Pharmacotherapy CrossRef
  25. Targeting pancreatic cancer cells by a novel hydroxamate-based histone deacetylase (HDAC) inhibitor ST-3595
    Shang Minjie et al, 2015, Tumor Biol. CrossRef
  26. Molecular Insight in the Multifunctional Effects of Oridonin
    Brice Ayissi Owona et al, 2015, Drugs R D CrossRef
  27. Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity
    Wei Hou et al, 2019, ACAMC CrossRef
  28. Oridonin Suppresses Proliferation of Human Ovarian Cancer Cells via Blockage of mTOR Signaling
    Rong Xia et al, 2016, Asian Pacific Journal of Cancer Prevention CrossRef
  29. The mitochondrion interfering compound NPC-26 exerts potent anti-pancreatic cancer cell activity in vitro and in vivo
    Yang-Yang Dong et al, 2016, Tumor Biol. CrossRef
  30. Anticancer activities and mechanisms of heat-clearing and detoxicating traditional Chinese herbal medicine
    Yulin Zhang et al, 2017, Chin Med CrossRef
  31. null
    C. Ding et al, 2017 CrossRef
  32. Arenobufagin Inhibits the Phosphatidylinositol 3-kinase/Protein Kinase B/Mammalian Target of Rapamycin Pathway and Induces Apoptosis and Autophagy in Pancreatic Cancer Cells.
    Xiaolu Wei et al, 2020, Pancreas CrossRef
  33. Preclinical study of cinobufagin as a promising anti-colorectal cancer agent
    Xing-sheng Lu et al, 2017, Oncotarget CrossRef
  34. Oridonin enhances γ‑globin expression in erythroid precursors from patients with β‑thalassemia via activation of p38 MAPK signaling
    Lishan Guo et al, 2019, Mol Med Report CrossRef
  35. Oridonin inhibits growth and induces apoptosis of human neurocytoma cells via the Wnt/β‑catenin pathway
    Jingyan Liang et al, 2018, Oncol Lett CrossRef
  36. The therapeutic effect of the BRD4-degrading PROTAC A1874 in human colon cancer cells
    An-cheng Qin et al, 2020, Cell Death Dis CrossRef
  37. Oridonin interferes with simple steatosis of liver cells by regulating autophagy
    Boning Cheng et al, 2021, Tissue and Cell CrossRef
  38. Oridonin inhibits SASP by blocking p38 and NF-κB pathways in senescent cells
    Shusuke Yasuda et al, 2022, Biochemical and Biophysical Research Communications CrossRef
  39. The potential roles of p53 signaling reactivation in pancreatic cancer therapy
    Aixin Ou et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  40. Herbals and Plants in the Treatment of Pancreatic Cancer: A Systematic Review of Experimental and Clinical Studies
    John K. Triantafillidis et al, 2022, Nutrients CrossRef
  41. null
    Roohi Mohi-ud-din et al, 2022 CrossRef
  42. De Novo design of a humanized antiCD33 antibody-oridonin conjugate for acute myeloid leukemia therapy
    Hui Feng et al, 2022, Biochemical and Biophysical Research Communications CrossRef
  43. Advances in the treatment of pancreatic cancer with traditional Chinese medicine
    Yanhua Zhang et al, 2023, Front. Pharmacol. CrossRef
  44. Oridonin from Rabdosia rubescens: An emerging potential in cancer therapy – A comprehensive review
    Muhammad Asif Ali et al, 2024, Food Science & Nutrition CrossRef
  45. The Natural Product Oridonin as an Anticancer Agent: Current Achievements and Problems
    Xiangyan Hu et al, 2024, CPB CrossRef